24.12.2012 Views

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SYMPOSIA SESSIONS<br />

50<br />

Symposia <strong>Session</strong>s<br />

Symposium 08: Therapeutic Vaccination and Strategies for the Cure<br />

S08.<strong>01</strong><br />

Therapeutic Approaches to Curing <strong>HIV</strong> Infection<br />

S Deeks 1<br />

1 University of California, San Francisco, San Francisco, CA, USA<br />

The current therapeutic strategy for established <strong>HIV</strong> infection is<br />

to control viral replication with combination antiretroviral drugs.<br />

This approach has limitations as it does not restore health and<br />

as many individuals have trouble accessing and/or adhering<br />

to these drugs on indefinite manner. Recognizing the need<br />

for a therapy that is short-term and scalable, there is intense<br />

interesting in potentially curative approaches. There are now a<br />

number of potential cure strategies being tested in pre-clinical<br />

animal models, with several now advancing into phase I human<br />

clinical trials. The status of these approaches will be summarized.<br />

AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />

S08.02<br />

Therapeutic <strong>Vaccine</strong>s in Strategies for Functional<br />

Cure of <strong>HIV</strong><br />

B. Autran 1<br />

1 JINSERM U543 - Université Paris VI Pierre et Marie Curie,<br />

ORVACS, Paris, France

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!